Skip to main content

Table 1 Clinical and pathological data of 3 cases of small bowel MEITL

From: Clinicopathological and molecular genetic alterations in monomorphic–epitheliotropic intestinal T-cell lymphoma of the small intestine

Case

Sex/age (years)

symptom

Laboratory tests

Tumor site

Size of swelling (cm3)

Initial diagnosis

Interoperative view

Curing

Prognosis (survival time)

1

Female/61

Abdominal distension with obstruction

CRP: 35.9 mg/L

LDH: 621 U/L CA125: 401.5U/mL

ileum (anatomy)

13 × 8 × 6

small bowel syndrome

Thickening of the intestinal wall and narrowing of the intestinal canal

Surgery + CHOP

At 17 months of follow-up, the patient died

2

Male/67

Abdominal pain, bloody stool with perforation

CRP: 63.24 UI/L

LDH: 524.1U/L

CAl25: 186.3 U/mL

empty stomach

3 × 2 × 2

perforated intestine

Ulcerative mass with perforation/bleeding in the intestinal wall

Surgery + CHOP

At 8 months of follow-up, the patient died

3

Female /73

Epigastric distension with obstruction

CRP: 22.7 mg/L

LDH: 247 U/L

CAl25: 106.7 U/mL

empty stomach

5 × 3 × 2

Small bowel occupation with obstruction

Hard mass in the intestinal wall

Surgery + CPCT + Chinese medicine

Alive (5 months)

  1. LDH: (106–300 U/L), CRP: (0–5.0 mg/L), CA125: (0–35 U/mL). CHOP: cyclophosphamide + vincristine + epirubicin + prednisone. CPCT cedarbenzamide, prednisone, cyclophosphamide, thalidomide